title: A patient with myeloma who still has pure red cell aplasia despite the most intensive immune modulation.
authors.affiliation: Department of Haematology, Royal Bournemouth Hospital, U.K.
authors.forename: J
authors.initials: J
authors.lastname: Orchard
authors.forename: H
authors.initials: H
authors.lastname: Myint
authors.forename: T J
authors.initials: TJ
authors.lastname: Hamblin
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000328:Adult; D001803:Blood Transfusion; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000150:complications*; D012010:Red-Cell Aplasia, Pure / Q000150:complications* / Q000276:immunology / Q000628:therapy
chemical_list: D000276:Adjuvants, Immunologic